Editor Name: M Kadri Altundag
Country: Turkey
University: Hacettepe University Cancer
Institute
Designation: professor of Medical
Oncology
Department: Medical Oncology
Email: altundag66@yahoo.com / drkadri@usa.net
BIOGRAPHY:
He has a professor of Medical Oncology
at Hacettepe University Cancer Institute. My main interest area is breast
cancer. I had been at MD Anderson Cancer Center, Texas, USA between 2004-2006
as visiting scientist and worked there at Breast Medical Oncology Unit. He had
breast cancer breast cancer presentations at both international and national
conferences. He conducted more than 30 international breast cancer clinical
studies. I had my own breast cancer patients since 2006 more than 5000
patients. Fort the last 4-5 years, I saw 60-80 newly diagnosed breast cancer
patients every month. He had 629 international publications and 207
international abstracts and 5509 citations
Websites: www.kadrialtundag.com / www.drkadrialtundag.com
PUBLICATIONS:
1. Benekli M, Güllü İH, Savaş C,
Kadayıfçı A, Altundağ MK, Tekuzman G, Fırat D. Acute Tumor Lysis Syndrome
Following Intrathecal Methotrexate. Leukemia and Lymphoma 1996; 22:361-363.
2. Kars A, Çelik İ, Kansu E, Tekuzman
G, Özışık Y, Güler N, Barışta İ, Güllü İ,Yalçın Ş, Altundağ K,
Zengin N, Türker A, Hayran M, Baltalı E, Fırat D. Maintenance Therapy with
Alpha-Interferon Following First-Line VAD in Multiple Myeloma. European Journal
of Haematology 1997;59(2):100-104
3. Öztürk MA, Benekli M, Güler N,
Altundağ MK, Barışta İ, Ayhan A. Gastric Adenocarcinoma Metastasis to the
Parotid Gland. Journal of Clinical Gastroenterology 1997; 25:698-699.
4. Altundağ MK, Barışta İ.
False-positive Urine Melanin Pigment Reaction Caused by Rifampin. The Annals of
Pharmacotherapy 1998;32(5):610.
5. Yalçın Ş, Altundağ K, Asıl M,
Tekuzman G. Sublingual Piroxicam for Cancer Pain. Medical Oncology 1998;15:137-139.
6. Öztürk A, Benekli M, Altundağ K,
Güler N. Squamous cell carcinoma of the skin associates with systemic
sclerosis. Dermatological Surgery 1998;24:777-779.
7. Çelik İ, Altundağ K, Erman M,
Baltalı E. Cyclophosphamide-associated Carcinoma of the Urinary Bladder in
Behçet’s Disease. Nephron 1999; 81: 239.
8. Akata D, Aralasmak A, Ozmen MN,
Akhan O, Altundağ K, Güllü İ. US and CT findings of multicentric
leiomyosarcomatosis. European Journal of Radiology 1999; 9: 711-714.
9. Güler N, Baltalı E, Altundağ K,
Zengin N, Tekuzman G, Özışık Y, Fırat D. Paclitaxel in the salvage
treatment of metastatic breast carcinoma. Journal of Balkan Union of Oncology
1999;4:275-281.
10. Barışta İ, Tekuzman G, Yalçın
Ş, Güllü İ, Güler N, Özışık Y, Kars A, Çelik İ, Türker A, Altundağ
K, Zengin N, Üner A, Baltalı E, Fırat D. Treatment of advanced soft tissue
sarcomas with ifosfamide and doxorubicin combination chemotherapy. Journal of
Surgical Oncology 2000;73:12-16.
11. Altundağ MK, Çelik İ. Human
Immunodeficiency Virus Negative Kaposi Sarcoma and Lymphoproliferative
disorders. Cancer 2000;88:708-709.
12. Altundağ MK, Özışık Y,
Yalçın Ş, Akyol F, Üner A. Primary low grade B-cell lymphoma of the dura in
an immunocompetent patient. Journal of Experimental and Clinical Cancer
Research 2000;19:249-251.
13. Yılmaz M, Farsak B, Altundağ MK,
Demircin M, Özkutlu S, Paşaoğlu İ. Isolated cardiac metastasis of
osteosarcoma. Journal of Experimental and Clinical Cancer Research
2000;19:395-397
14. Kömürcü Ş, Özet A, Öztürk B,
Arpacı F, Altundağ MK, Tezcan Y. Colon cancer during pregnancy: a case report
and review of the literature. The Journal of Reproductive Medicine
2001;46:75-78.
15. Baltalı E, Özışık Y, Güler N,
Fırat D, Altundağ K. Combination of docetaxel and doxorubicin as first-line
chemotherapy in metastatic breast cancer. Tumori 2001;87:18-19.
16. Köklü S, Barışta İ, Altundağ
MK, Aksu S, Fırat P. An unusual case of metastatic rectal carcinoma presenting
as thyroid nodule. The American Journal of Gastroenterology 2000;95:3689.
17. Altundağ MK, Çelik İ, Özışık
Y. Is there a range of time for initiation of adjuvant chemotherapy in patients
with malignancy? Annals of Oncology 2000;11:1209.
18. Hasegeli Üner A, Abalı H, Engin
H, Akyol A, Ruacan Ş, Tan E, Güllü İ, Altundağ K, Güler N. Myasthenia
Gravis and lymphphoblastic lymphoma involving the thymus; a rare association.
Leukemia and Lymphoma 2001;42:527-531..
19. Cengiz M, AltundaÄŸ MK, Zorlu AF,
Güllü İH, Özyar E, Atahan İL. Malignancy in Behçet’s disease: Report of
thirteen cases and a review of the literature. Clinical Rheumatology
2001;20:239-244.
20. Abalı H, Altundağ MK, Engin H,
Altundağ ÖÖ, Türker A, Üner A, Ruacan Ş. Hypereosinophlia and metastatic
anaplastic carcinoma of unknown primary. Medical Oncology 2001;18:285-288.
21. Köklü S, Onat AM, Erol K,
Kılıçarslan A, Altundağ MK, Güllü İ. Relapsed prolactinoma 27 years
after conventional radiotherapy. American Journal of Clinical Oncology
2002;25:429-430..
22. Kömürcü Ş, Özet A, Altundağ
MK, Arpacı F, Öztürk B, Celasun B, Tezcan Y. Vanishing bile duct syndrome
occurring after high dose chemotherapy and autologous peripheral stem cell
transplantation in a patient with Hodgkins disease. Annals of Hematology
2002;81:57-58.
23. Akbay A, Altundağ MK, Özışık Y,
Zorlu AF, PalaoÄŸlu S. Reverse seeding of recurrent intraspinal malignant
meningioma. Oncology-International Journal of Cancer Research and Treatment
2002;62:386-388.
For
More Articles: http://www.drkadrialtundag.com/yayin-listesi
Google
Scholar: https://scholar.google.com/citations?user=9JH1UFYAAAAJ&hl=en
ResearchGate: https://www.researchgate.net/profile/Kadri_Altundag